Published
08 July 2009 | By Centre for Human Drug Research
Hit the mark. Joop van Gerven and Justin Hay of CHDR discuss how carefully chosen biomarkers can easily be incorporated into early phase drug studies, providing guidance for important decisions concerning a drug's future.
Sorry for the inconvenience, There is no whitepaper to download.Related Intelligence and Suppliers
White Papers
Future of Cardiovascular Drug Development
Centre for Human Drug Research
White Papers
Proof of Pharmacological Principle
Centre for Human Drug Research
White Papers
Latest Products
The NeuroCart
The NeuroCart is an unrivaled translational tool, measuring neuropsychological and neurophysiological functions of the brain. It is a proprietary test battery quantifying potential effects of new investigational drugs.
Products
Suppliers
Centre for Human Drug Research - Early Phase Drug Development
The Centre for Human Drug Research (CHDR) performs clinical studies of innovative medicines with the concept where the maximum amount of information is extracted in the earliest clinical phase, using innovative and complex techniques as reflected in our publication output.
Suppliers
Production & Manufacturing
Fine & Speciality Chemicals
Manufacturing
Process & Production
OTC
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs
